Company intelligence / Profile preview

Shengjia

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Shengjia Biotechnology is a Chinese life sciences company specializing in the development and manufacturing of molecular diagnostic reagents and automated laboratory systems. The company focuses on high-performance PCR reagents, NGS library preparation kits, and nucleic acid extraction technologies to support clinical diagnostics and research. Shengjia provides a comprehensive portfolio of products for the detection of infectious diseases, genetic testing, and oncology-related molecular analysis. Their business model encompasses both the production of standardized diagnostic kits and the provision of customized solutions for life science laboratories and healthcare institutions.

Therapeutic areas: Infectious DiseasesRare DiseasesOncology
Modalities: Molecular DiagnosticsPCRNext-Generation Sequencing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Shengjia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shengjia.

Explore the full profile